Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma-Reference-Cited by-同舟云学术

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma

Published:2018-03 Issue:1-2 Volume:34 Page:40-51
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Lin Cheng-Wen¹,Sherman Bryan¹,Moore Lori A.¹,Laethem Carmen L.¹,Lu Da-Wen²,Pattabiraman Padmanabhan P.³,Rao Ponugoti Vasantha³,deLong Mitchell A.¹,Kopczynski Casey C.¹

Affiliation:

1. Aerie Pharmaceuticals, Inc., Durham, North Carolina.

2. National Defense Medical Center, Taipei City, Taiwan.

3. Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2017.0023

Reference44 articles.

1. Medical Management of Glaucoma

2. Definition of glaucoma: clinical and experimental concepts

3. The neurobiology of cell death in glaucoma

4. Current management of glaucoma

5. Current understanding of conventional outflow dysfunction in glaucoma

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Rho Kinase Inhibitors in Corneal Diseases;Drug Design, Development and Therapy;2024-01

2. Inhibition of TGF-β2–Induced Trabecular Meshwork Fibrosis by Pirfenidone;Translational Vision Science & Technology;2023-11-17

3. ROCK Inhibitors as an Alternative Therapy for Corneal Grafting: A Systematic Review;Journal of Ocular Pharmacology and Therapeutics;2023-11-01

4. Role of integrins in the development of fibrosis in the trabecular meshwork;Frontiers in Ophthalmology;2023-10-24

5. Other Kinase Inhibitors;Molecules Engineered Against Oncogenic Proteins and Cancer;2023-09-08